Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma.

Laila KönigKlaus HerfarthJuliane Hörner-RieberSascha DietrichThomas WiegelJürgen DebusAndreas Viardot

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2020)

The real-world efficacy of RIT is comparable with the results of the MIR study. Additionally, this analysis shows that extranodal involvement and grade 3A histology are not associated with inferior PFS.

Keyphrases

early stage
cell proliferation
diffuse large b cell lymphoma
lymph node
long noncoding rna
minimally invasive
radical prostatectomy
sentinel lymph node